共 89 条
[1]
Engerman RL, Bloodworth JMB, Experimental diabetic retinopathy, Invest Ophthalmol, 3, pp. 466-467, (1964)
[2]
Hausler HR, Sibay TM, Campbell J, Retinopathy in a dog following diabetes induced by growth hormone, Diabetes, 13, pp. 122-126, (1964)
[3]
Engerman RL, Bloodworth JMB, Experimental diabetic retinopathy in dogs, Arch Ophthalmol, 73, pp. 205-210, (1965)
[4]
Engerman RL, Meyer RK, Buesseler JA, Effects of alloxan diabetes and steroid hypertension on retinal vasculature, Am J Ophthalmol, 58, pp. 965-978, (1964)
[5]
Toussaint D, pp. 108-148, (1968)
[6]
Engerman RL, Finkelstein D, Aguirre G, Diddie K, Fox R, Frank R, Varma S, Appropriate animal models for research on human diabetes mellitus and its complications. Ocular complications, Diabetes, 31, 1, pp. 82-88, (1982)
[7]
Engerman RL, Davis MD, Bloodworth JMB, Retinopathy in experimental diabetes: its relevance to diabetic retinopathy in man, Diabetes, Proc VII Congr Int Diab Fed, pp. 261-267, (1971)
[8]
Engerman RL, Kern TS, Progression of incipient diabetic retinopathy during good glycemic control, Diabetes, 36, pp. 808-812, (1987)
[9]
Engerman RL, Kern TS, Retinopathy in galactose‐fed dogs continues to progress after cessation of galactosemia, Arch Ophthalmol, 113, pp. 355-358, (1995)
[10]
Gardiner TA, Stitt AW, Anderson HR, Archer DB, Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs, British Journal of Ophthalmology, 78, pp. 54-60, (1994)